JPRN-UMIN000007664已完成未知
Oral propranolol therapy for infantile hemangiomas - Oral propranolol therapy for infantile hemangiomas
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patient who has a severe complication without infantile hemangiomas 2.Patient with the past of serious side effect by the propranolol drug 3.Patient with asthma or carbohydrate metabolism 4.Patient who was considered ineligible by the investigators
研究者
相似试验
已完成
不适用
Propranolol therapy for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000005990Tohoku University Hospital
已完成
不适用
Propranolol for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000011944Plastic and Reconstructive Surgery, Keio university, School of medicine30
已完成
不适用
Efficacy of proplanorol for infantile hemangiomaInfantile HemangiomaJPRN-UMIN000020220Tohoku University Hospital25
已完成
2 期
Effect of oral propranolol on benign vascular tumors in children under 15 yearsCutaneous hemangioma.D18.1?D18.0IRCT2015011920715N1Arak University Of Medical Science32
招募中
不适用
Propranolol and Von Hippel-Lindau DiseaseHemangioblastoma of CNSVon Hippel-Lindau DiseaseNCT05424016Assistance Publique - Hôpitaux de Paris85